KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Astrana Health (ASTH) Non-Current Receivables (2016 - 2025)

Astrana Health (ASTH) has disclosed Non-Current Receivables for 10 consecutive years, with $26.2 million as the latest value for Q4 2025.

  • Quarterly Non-Current Receivables rose 64.46% to $26.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.2 million through Dec 2025, up 64.46% year-over-year, with the annual reading at $26.2 million for FY2025, 64.46% up from the prior year.
  • Non-Current Receivables hit $26.2 million in Q4 2025 for Astrana Health, up from $15.9 million in the prior quarter.
  • In the past five years, Non-Current Receivables ranged from a high of $48.4 million in Q2 2025 to a low of $569000.0 in Q4 2021.
  • Historically, Non-Current Receivables has averaged $16.4 million across 5 years, with a median of $15.9 million in 2022.
  • Biggest five-year swings in Non-Current Receivables: crashed 86.27% in 2021 and later soared 203.39% in 2025.
  • Year by year, Non-Current Receivables stood at $569000.0 in 2021, then skyrocketed by 2701.93% to $15.9 million in 2022, then soared by 66.05% to $26.5 million in 2023, then tumbled by 39.78% to $15.9 million in 2024, then surged by 64.46% to $26.2 million in 2025.
  • Business Quant data shows Non-Current Receivables for ASTH at $26.2 million in Q4 2025, $15.9 million in Q3 2025, and $48.4 million in Q2 2025.